Mithrl Inc.

Happening next week: We’re excited to sponsor the Data Driven Pharma Forum at @genentech on May 27. This year’s theme takes on a critical question: where do drug development costs really sit, what can AI meaningfully improve, and how do we know if it’s actually working? Join leaders from Genentech, @GileadSciences, and @GSK for a candid conversation on the evolving role of AI in drug development. Attendees will also hear from Mithrl Co-Founder & CEO Vivek Adarsh, PhD, who will kick off the event with a live Mithrl tech demo. 📍 Genentech, South San Francisco, CA 🗓 Wednesday, May 27, 2026 ⏰ 4–8 PM PDT Register here: bit.ly/4tg7OyC #DataDrivenPharma #AIinPharma #DrugDevelopment

Final day at #BioITExpo in Boston! It’s been a fantastic week connecting with leaders across biopharma, AI, precision medicine, and biomedical research. We’ve appreciated everyone who stopped by our booth to meet the Mithrl team, see our platform in action, and discuss the future of AI-driven R&D. It’s also been great engaging with attendees during conference sessions and conversations around AI, bioinformatics, and scientific decision-making. If you’re attending today, there’s still time to stop by booth #802 before the exhibit hall closes at 2:30 PM. If you’re unable to make it, you can still request a virtual demo here: bit.ly/4pgzmlJ #BioITWorld #BioITExpo #Biopharma #PrecisionMedicine #Multiomics #AIinBiotech

📢 Happening today at #BioITExpo in Boston: Mithrl team members are leading conversations at the intersection of AI, bioinformatics, and precision medicine. • Brigitte Ganter, GTM & Product Strategy at Mithrl, is chairing the session “Next-Generation Bioinformatics for Precision Medicine and Cancer Genomics” | 10:15 AM • Vivek Adarsh, PhD, Co-Founder & CEO at Mithrl, will be participating in two sessions: – Chairperson’s Remarks: “AI-Enhanced Discovery and Multimodal Insights in Precision Oncology” | 10:15 AM – Speaking Session: “More Data, Less Insight: Why Scientific AI Needs a New Framework" | 2:30 PM If you’re attending #BioITExpo, stop by booth #802 for a free ice cream treat and to connect with the Mithrl team about transparent, reproducible AI for biopharma R&D. #BioITWorld #BioIT2026 #PrecisionMedicine #Bioinformatics @bioitworld @brigittegs @flyingthor

Don’t miss Vivek Adarsh, PhD, Co-Founder & CEO of Mithrl, at #BioITExpo on Wednesday, May 20: • Chairing “AI-Enhanced Discovery and Multimodal Insights in Precision Oncology” at 10:15 AM (Track T7: AI for Oncology, Precision Medicine, and Health) • Speaking on “More Data, Less Insight: Why Scientific AI Needs a New Framework” at 2:15 PM (Track T7: AI for Oncology, Precision Medicine, and Health)

Precision oncology is generating more data than ever across genomics, transcriptomics, imaging, spatial biology, and clinical outcomes. But more data doesn’t automatically create better insight. Many research teams still face fragmented workflows, delayed analysis, and limited transparency in how conclusions are reached, making reproducibility and scientific trust difficult to achieve at scale. As AI adoption accelerates across biopharma R&D, the challenge is no longer just speed. It’s generating reproducible, reviewable, and scientifically defensible insights from complex multimodal data. In our latest article, Vivek Adarsh, PhD, Co-Founder & CEO of Mithrl, explores why precision oncology remains rich in data but poor in insight, and how transparent scientific AI may help bridge the gap. Read more: bit.ly/4foBAxu #PrecisionOncology #AIinBiotech #CancerResearch #Bioinformatics #PrecisionMedicine #DrugDiscovery #BioITExpo @bioitworld @flyingthor

We’re back in Boston this week for #BioITExpo, continuing the conversation around AI, biomedical research, and data-driven discovery. 📍 Stop by Booth #802 for a free ice cream treat and a live look at Mithrl’s Scientific Decision Engine for biomedical and biopharma R&D teams. Members of the Mithrl team will also be speaking and chairing sessions throughout the conference. 🧬 See how Mithrl enables: • Transparent, verifiable AI for biomedical research • Reproducible analysis across multimodal datasets • Multi-agent workflows for biopharma R&D • Natural language interaction with complex scientific data #BioITWorld #Biopharma #DrugDiscovery #Multiomics #AIinBiotech @bioitworld

Come see us at booth #802 for a live look at Mithrl’s Scientific Decision Engine for biomedical and biopharma R&D teams. #BioITExpo

Bioinformatics is at a crossroads. The life sciences industry is generating more biological data than ever before, yet turning that data into reproducible, clinically meaningful insight remains one of the field’s greatest challenges. The bottleneck is no longer data generation. It’s insight generation. In our latest article, Brigitte Ganter, GTM & Product Strategy at Mithrl, explores the growing challenges surrounding multi-omics complexity, reproducibility, AI adoption, and the “final mile” between computational discovery and real-world clinical impact. As Bio-IT World approaches, these conversations are becoming increasingly important for the future of precision medicine and biopharma R&D. Read the full article: bit.ly/4uJTSOc #BioITExpo #Bioinformatics #PrecisionMedicine #Biopharma @brigittegs @bioitworld

May is National Cancer Research Month, a time to recognize progress across oncology and the work still ahead. Across recent industry conversations, including at #AACR26, one theme stood out: the challenge is no longer just generating more data, but enabling faster, more reliable decision-making from increasingly complex datasets. As modalities expand, connecting signals in a rigorous, reproducible, and clinically meaningful way is becoming a critical bottleneck. The conversation is shifting from whether AI has a role to how it can be evaluated and trusted in real-world scientific workflows. We believe the next phase of cancer research will be shaped not only by biological discovery but also by the infrastructure that enables teams to translate data into defensible, decision-ready insights. This month and always, Mithrl is committed to advancing cancer research through more transparent, reproducible, and scalable approaches to scientific decision-making. Learn more: bit.ly/3Lsmt9h Heading to Boston for #BioITExpo next week? Visit us at booth #802. #NationalCancerResearchMonth #Oncology #CancerResearch #ImmunoOncology #AIinBiology

Visit the Mithrl team at booth #850 for live demos, conversations around transparent AI for biopharma R&D, and free Ben & Jerry’s ice cream while supplies last. #ASGCT2026

🚨 Happening today at #ASGCT2026 in Boston How can AI help accelerate cell and gene therapy R&D while remaining transparent, traceable, and scientifically defensible? Join Mithrl's Co-Founder & CEO, Vivek Adarsh, this afternoon for a session on how verifiable AI agents are helping research teams translate complex omics data into reproducible, decision-ready insights. From Target to IND: Verifiable AI Agents for Cell and Gene Therapy 📅 May 14 ⏰ 3:15–3:30 PM Stop by Mithrl at booth #850 for live demos, conversations around transparent AI for biopharma R&D, and free Ben & Jerry’s ice cream while supplies last. Book a 1:1 meeting with the team: bit.ly/42K2iZR #CellAndGeneTherapy #Omics #DrugDiscovery #AIinBiotech @ASGCTherapy

Pick your flavor, #ASGCT2026! 🍦 Come find us at booth #850 for free Ben & Jerry’s, live demos, and enterprise-ready AI built to power cell and gene therapy discovery from omics and multi-modal data. See how Mithrl helps teams: • Turn complex data into reproducible, decision-ready insights • Accelerate R&D with transparent, verifiable AI agents • Improve traceability across scientific workflows • Move from raw data to defensible scientific decisions faster Plus, don’t miss our talk tomorrow: “From Target to IND: Verifiable AI Agents for Cell and Gene Therapy” 🗓 Thursday, May 14 ⏰ 3:15–3:30 PM We’re showcasing live demos throughout the day. Stop by booth #850 and say hello to the Mithrl team! #ASGCT #CellandGeneTherapy @ASGCTherapy

We’re here at #ASGCT2026! Stop by booth #850 for free Ben & Jerry’s ice cream while supplies last, and see how Mithrl helps biopharma teams accelerate CGT discovery research with reproducible, transparent analysis of complex omics and multimodal data.

We’ve arrived in Boston for #ASGCT2026! Free Ben & Jerry’s ice cream while supplies last and valuable insights from your data. If you're attending this week, stop by booth #850 to see how Mithrl’s Scientific Decision Engine helps biopharma teams accelerate CGT discovery research with reproducible, transparent analysis of complex omics and multi-modal data. Don’t miss our upcoming talk this Thursday: From Target to IND: Verifiable AI Agents for Cell and Gene Therapy May 14 | 3:15–3:30 PM Presented by Vivek Adarsh, PhD, Co-Founder & CEO Stop by or schedule a 1:1 meeting with us: bit.ly/42K2iZR Onsite is Vivek Adarsh (@flyingthor), Sarosh Naseem, Rachel van der Lugt (@LugtRachel38704), Allegra Messinese (@Ames24704), and Keara Brosnan. We can't wait to meet you! #CellAndGeneTherapy #Omics #DrugDiscovery #Mithrl @ASGCTherapy

The wait is over – welcome to Boston! 🎉 We are so excited to bring together the global cell and gene therapy community for an unforgettable week of science and connection at #ASGCT2026. Let's get started!

Join the Bio-IT World Conference & Expo (May 19–21, Boston) and hear from leaders shaping the future of AI, data science & precision medicine. Keynotes + exhibits + networking—all in one pass. Complimentary until this Friday, April 10—register now. tinyurl.com/yvkh7nwu #BioITExpo

Next week, join Mithrl in Boston for the Bio-IT World Conference & Expo, where leaders across biopharma, AI, and precision medicine come together to shape the future of R&D. Visit us at booth #802 to see how Mithrl’s Scientific Decision Engine helps biopharma and research teams turn complex omics and multi-modal data into reproducible, transparent, and decision-ready insights. We’ll also be participating in the conference program with an upcoming talk. More details to come. See you in Boston: bit.ly/2GBd4Lp #BioITExpo #BioITWorld #Biopharma #DrugDiscovery #Omics #AI #TranslationalResearch @bioitworld

Boston, we’re ready for you! Join Mithrl at the American Society of Gene & Cell Therapy Annual Meeting 2026 (#ASGCT2026) next week. If you're attending, don’t miss our upcoming talk next Thursday: From Target to IND: Verifiable AI Agents for Cell and Gene Therapy May 14 | 3:15–3:30 PM Presented by Vivek Adarsh, PhD, Co-Founder & CEO Visit us at Booth #850 for live demos and see how Mithrl’s Scientific Decision Engine helps biopharma teams turn complex omics and multi-modal data into reproducible, transparent, and decision-ready insights. Book a 1:1 meeting with us at the booth: bit.ly/42K2iZR Let’s talk about what trustworthy AI can unlock for cell and gene therapy! #CellAndGeneTherapy #Omics #DrugDiscovery #Mithrl @ASGCTherapy

Final day of #SynBioBeta2026! If you’re here, stop by booth #804 to see live demos of Mithrl’s Scientific Decision Engine and learn how we help biopharma and academic research teams turn complex omics data into reproducible, decision-ready insights. Shiloh Barfield and Rachel van der Lugt will be at the booth throughout the day and are excited to meet fellow researchers working across discovery research. Huge shout-out to the @SynBioBeta team for hosting such an outstanding conference. We’re having a great time making new connections and especially love the cell art poster and the tribute to the legend Dr. Craig Venter (1946–2026). A memorable touch from the SynBioBeta team. IYKYK. #Biopharma #DrugDiscovery #Omics #AI @ShilohB66714 @LugtRachel38704 @johncumbers